credit where credit

is due for ro

Problem statement

Cities turning treated wastewater into drinking water must prove, continuously, that their treatment train removes pathogens to a regulated log-reduction target, and reverse osmosis (RO) is the workhorse barrier. Intact RO membranes reject viruses by 6-log10 or more (99.9999%), because even the smallest waterborne viruses are ~10× larger than the 0.4–0.9 nm membrane pores. Yet regulators typically credit RO with only 1.5–2 log10 of virus removal, and in Texas with none. The reason is measurement, not performance: crediting relies on a surrogate that can be measured online and correlates with virus passage, and the surrogates in use — conductivity and total organic carbon — are made of small ions and molecules that RO rejects far less completely than it rejects viruses, so they saturate at ~2 log10. As the report puts it, "it's not about what you can remove, but what you can prove." No known naturally occurring constituent of RO feedwater is consistently removed by more than 3-log10, so the gap between real and credited virus removal cannot be closed with existing tools.

Why this matters

Under-crediting RO forces potable-reuse utilities to add or oversize other barriers (UV/advanced oxidation, additional filtration, longer environmental buffers) to reach total pathogen log-reduction requirements that RO alone could largely satisfy — adding capital cost, energy and chemical use to projects that are already the most expensive water-supply option many cities have. It also creates inconsistency: California credits RO through bulk parameters, Texas gives it zero, and direct potable reuse rules are pushing toward stricter, membrane-guidance-manual-style frameworks. Water-scarce regions planning direct potable reuse in the next decade will lock in treatment-train designs based on whatever crediting is available now, so a better surrogate has an outsized effect on the cost and footprint of the coming generation of reuse plants.

What’s been tried and why it hasn’t worked

Direct integrity testing — pressure-decay tests that work for ultrafiltration — cannot be applied to RO, so RO relies on indirect surrogates. Conductivity and TOC are cheap and continuous but "highly conservative because they are orders of magnitude smaller than pathogens," yielding 1.5–2 log10 at best; they also fail the guidance definition of direct integrity monitoring because they are bulk measures. Naturally occurring multivalent ions — sulfate, strontium, calcium, magnesium — are rejected better and can support ~3 log10 and have been approved on several Southern California projects, but the online analyzers for specific compounds "are typically expensive and require highly trained lab staff," otherwise daily grab samples must go to a lab, and 3 log10 still leaves a 3-log10 shortfall. Spiked surrogates (uncharged sucrose, fluorescent tracers such as 3D TRASAR) reach ~2.5–3 log10 with online sensors, but carry "cost and complexity to spike in the compounds and unresolved questions about the effect of the compounds on membrane fouling," and "this approach has not been used in full-scale potable reuse projects and has not received regulatory approval." Modeling approaches that link conductivity rejection to virus rejection require a robust integrity program (daily per-vessel conductivity profiles with a dilution model) and "more research is required to acquire regulatory approval." Open questions compound the technical gap: whether daily specific-ion measurement counts as direct integrity testing; and what monitoring resolution (system, train, or individual pressure vessel) regulators should require, given that "major losses in virus removal efficiency only occur when integrity is severely compromised."

What would unlock progress

The report's stated need is a surrogate it labels the "UNICORN": a naturally present, individual compound, continuously measurable with an affordable online sensor, whose rejection tracks virus rejection up to ~6 log10 in both intact and compromised membranes. Short of that, progress could come from an inexpensive online sensor for an already-approved multivalent ion (turning a lab measurement into a continuous one), a spiked marker with demonstrated fouling neutrality, or a validated per-vessel conductivity-profiling model that regulators accept for crediting above the bulk-parameter ceiling. The analogous problem was solved for ultrafiltration by pressure-decay testing; RO needs its equivalent. Regulatory clarity — updating the membrane guidance to address RO specifically — is the parallel unlock.

Entry points for student teams

A team could benchmark low-cost online sensing options for strontium or sulfate (ion-selective electrodes, spectroscopic methods) against lab ICP/IC on real RO feed and permeate from a partner utility, quantifying whether a sub-$10k analyzer can support 3-log10 crediting continuously. A modeling team could build and stress-test a per-vessel conductivity dilution model on a pilot RO skid, deliberately compromising O-rings to map how surrogate signals respond to real integrity breaches versus virus (MS2) passage. A regulatory-analysis team could compare how California, Texas and other states credit RO and draft a crediting framework proposal. Skills: membrane process engineering, analytical chemistry/sensors, statistical modeling, environmental microbiology, water regulation.